| Victor A Berdecia Perez, MD | |
|
2435 Ave Las Americas, Hosp Dr Pila Dept De Radiologia, Ponce, PR 00733 | |
| (787) 848-5600 | |
| (787) 843-9320 |
| Full Name | Victor A Berdecia Perez |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 35 Years |
| Location | 2435 Ave Las Americas, Ponce, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710019153 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 11442 (Puerto Rico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospital Menonita Caguas Inc | Caguas, PR | Hospital |
| Hospital Menonita De Cayey | Cayey, PR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospital Menonita De Cayey | 2466449657 | 12 |
News Archive
Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections.
A Mayo Clinic study has found that two genes in mice were associated with good central nervous system repair in multiple sclerosis (MS). These findings give researchers new hope for developing more effective therapies for patients with MS and for predicting MS patients' outcomes. This study will be presented at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, on Sept. 11, 2009.
MICARDIS® is the first treatment in its class to be approved for this indication. The EMEA approval is the second major milestone for MICARDIS® in cardiovascular protection. It follows the approval by the US FDA for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors.
Cancer survivors who live in rural areas aren't as healthy as their urban counterparts, according to new research from Wake Forest Baptist Medical Center.
› Verified 9 days ago
| Entity Name | Hospital Menonita De Cayey |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750317764 PECOS PAC ID: 2466449657 Enrollment ID: O20040429000135 |
News Archive
Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections.
A Mayo Clinic study has found that two genes in mice were associated with good central nervous system repair in multiple sclerosis (MS). These findings give researchers new hope for developing more effective therapies for patients with MS and for predicting MS patients' outcomes. This study will be presented at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, on Sept. 11, 2009.
MICARDIS® is the first treatment in its class to be approved for this indication. The EMEA approval is the second major milestone for MICARDIS® in cardiovascular protection. It follows the approval by the US FDA for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors.
Cancer survivors who live in rural areas aren't as healthy as their urban counterparts, according to new research from Wake Forest Baptist Medical Center.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Victor A Berdecia Perez, MD Po Box 801143, Coto Laurel, PR 00780-1143 Ph: (787) 843-9320 | Victor A Berdecia Perez, MD 2435 Ave Las Americas, Hosp Dr Pila Dept De Radiologia, Ponce, PR 00733 Ph: (787) 848-5600 |
News Archive
Today, the U.S. Food and Drug Administration granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections.
A Mayo Clinic study has found that two genes in mice were associated with good central nervous system repair in multiple sclerosis (MS). These findings give researchers new hope for developing more effective therapies for patients with MS and for predicting MS patients' outcomes. This study will be presented at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, on Sept. 11, 2009.
MICARDIS® is the first treatment in its class to be approved for this indication. The EMEA approval is the second major milestone for MICARDIS® in cardiovascular protection. It follows the approval by the US FDA for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors.
Cancer survivors who live in rural areas aren't as healthy as their urban counterparts, according to new research from Wake Forest Baptist Medical Center.
› Verified 9 days ago
Dr. Desiree M Quinones Maymi, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 2435 Blvd Luis A Ferre, Hosp. Metropolitano Dr. Pila/depart. De Radiologia, Ponce, PR 00717 Phone: 787-848-5600 Fax: 787-842-9324 | |
Yadira G Mateo, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 172 Calle Bianca, Urb Terra Senorial, Ponce, PR 00731 Phone: 787-365-0498 | |
Carlos Remedios-carbone, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Edif Parras # 203, Ponce, PR 00717 Phone: 787-813-4401 Fax: 787-813-4403 | |
Santiago N Sallaberry-morciglio, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 2225 Ponce Byp Ste 105, Ponce By Pass, Ponce, PR 00717 Phone: 787-843-3080 Fax: 787-259-1585 | |
Dr. Miguel Angel Echevarria Rodriguez, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1326 Salud St, El Senorial Plaza Suite 105, Ponce, PR 00728 Phone: 787-840-3395 Fax: 787-844-2664 | |
Ramiro Milan Garces, MD Radiology Medicare: Medicare Enrolled Practice Location: 2435 Ave Las Americas, Hosp Dr Pila Dept Radologia, Ponce, PR 00733 Phone: 787-848-5600 Fax: 787-843-9320 |